Related Experiment Video
Updated: Jul 19, 2026
11:12
Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
Published on: October 17, 2013
Selection of prosthetic heart valves.
1Division of Cardiovascular and Thoracic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. rgallegos@partners.org
Current Treatment Options in Cardiovascular Medicine
|November 3, 2006
Summary
Heart valve replacement surgery has advanced, but no prosthetic valve matches natural function. Current options involve trade-offs between durability and risks like thrombosis, necessitating careful patient-specific treatment decisions.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Medical Device Engineering
Background:
- Heart valve repair and replacement surgery has evolved significantly since the 1960s.
- Current prosthetic heart valves do not fully replicate native valve durability, thrombogenicity, or hemodynamic function.
- Both bioprosthetic and mechanical valves present distinct challenges regarding longevity and patient safety.
Purpose of the Study:
- To review current recommendations for surgical intervention in heart valve disease.
- To analyze patient factors and valve-related complications in prosthetic heart valve selection.
- To discuss the limitations of existing prosthetic heart valve technologies.
Main Methods:
- Literature review of cardiovascular surgery advancements.
- Analysis of clinical data on prosthetic heart valve performance (durability, thrombogenicity, hemodynamics).
- Evaluation of patient factors influencing prosthetic valve choice.
Main Results:
- Bioprosthetic valves have high failure rates (approx. 45% at 10 years), especially in younger patients.
- Mechanical prostheses offer greater durability (>20 years) but have unresolved hemodynamic and thrombotic issues.
- No current prosthetic valve is fully comparable to the native human valve.
Conclusions:
- Selection of prosthetic heart valves requires careful consideration of patient age, lifestyle, and risk factors.
- Ongoing research is needed to develop prosthetic valves with improved durability and reduced thrombogenicity.
- Personalized treatment strategies are essential for optimal outcomes in heart valve disease management.
More Related Videos
Related Concept Videos
01:16Heart Valves
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.